Standard method for deriving stem cells may be better for use in regenerative medicine

February 5, 2016 by Mirabai Vogt-James, University of California, Los Angeles
Primed human embryonic stem cells (purple) surrounded by a stem cell surface marker (green), which would be missing in naïve embryonic stem cells. Credit: UCLA

Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have discovered an important naturally occurring process in the developing human embryo that can be lost when embryonic stem cells are derived in the lab.

The discovery provides scientists with critical information regarding the best method for creating stem cells for regenerative medicine purposes, such as cell transplantation or organ regeneration. The discovery also provides insight into how information that is passed from an unfertilized egg to an embryo may impact the quality of the embryo and subsequently, the birth of healthy children.

The findings were published in the journal Cell Stem Cell.

The research focuses on DNA methylation—a biochemical process that occurs naturally in DNA—in the early embryo and in stem cells created from embryos.

DNA methylation plays a role in how genetic information is used in the body. Correct DNA methylation of particular genes is critical for normal human development, and it remains critical in maintaining healthy cells throughout a person's lifespan. It also helps maintain an embryonic stem cell's ability to develop into any cell in the body.

The researchers made two important discoveries about DNA methylation. First, they discovered that an early-stage embryo, or blastocyst, retains the DNA methylation pattern from the egg for at least six days after fertilization. Prior to this discovery, scientists thought that methylation memory from the egg was only retained for a few hours after fertilization.

"We know that the six days after fertilization is a very critical time in human development, with many changes happening within that period," said Amander Clark, the study's lead author and a professor and vice chair of molecular, cell and developmental biology in the life sciences at UCLA. "It's not clear yet why the blastocyst retains methylation during this time period or what purpose it serves, but this finding opens up new areas of investigation into how methylation patterns built in the egg affect embryo quality and the birth of healthy children."

The team's second discovery reveals that using a recently adopted method to derive stem cells from embryos in a petri dish results in loss of methylation.

In the early embryo, the blastocyst stage of development lasts for less than five days. The less mature human embryonic cells that exist at the beginning of blastocyst development are called "naïve" embryonic cells. It is thought that at the time of implantation, these naïve embryonic cells reach a more mature state. They are then called "primed" , because they are primed to become every cell type in the body.

In 1998, when the first human embryonic stem cells were derived, scientists used a method that created primed stem cells. This was the standard method until recently, when scientists started using a different method that preserves the naïve stem cell state.

"In the past three years, naïve stem cells have been touted as potentially superior to primed cells," Clark said. "But our data show that the naïve method for creating stem cells results in cells that have problems, including the loss of methylation from important places in DNA. Therefore, until we have a way to create more stable naïve embryonic stem cells, the embryonic stem cells created for the purposes of regenerative medicine should be in a primed state in order to create the highest-quality cells for differentiation."

The two other UCLA Broad Stem Cell Research Center faculty members who collaborated on the study are Kathrin Plath, professor of biological chemistry in UCLA Life Sciences; and Steven Jacobsen, professor of molecular, cell and developmental biology in UCLA Life Sciences and an investigator with the Howard Hughes Medical Institute.

To further this research, Clark and Plath plan to work together to determine the optimal conditions for creating naïve that are more stable and retain methylation at places in the genome where it is most needed.

All human embryonic derived at the UCLA Broad Stem Cell Research Center are obtained from stored frozen embryos donated with informed consent by individuals or couples who have completed in vitro fertilization.

Explore further: How to detect and preserve human stem cells in the lab

More information: William A. Pastor et al. Naive Human Pluripotent Cells Feature a Methylation Landscape Devoid of Blastocyst or Germline Memory, Cell Stem Cell (2016). DOI: 10.1016/j.stem.2016.01.019

Related Stories

How to detect and preserve human stem cells in the lab

January 22, 2016
Human stem cells that are capable of becoming any other kind of cell in the body have previously only been acquired and cultivated with difficulty. Scientists at the Max Delbrück Center for Molecular Medicine (MDC) in the ...

Stem cells likely to be safe for use in regeneration medicine, study confirms

December 17, 2015
Cambridge researchers have found the strongest evidence to date that human pluripotent stem cells—cells that can give rise to all tissues of the body—will develop normally once transplanted into an embryo. The findings, ...

Recommended for you

Byproducts of 'junk DNA' implicated in cancer spread

August 14, 2018
The more scientists explore so-called "junk" DNA, the less the label seems to fit.

Doctors may be able to enlist a mysterious enzyme to stop internal bleeding

August 14, 2018
Blood platelets are like the sand bags of the body. Got a cut? Platelets pile in to clog the hole and stop the bleeding.

Artificial placenta created in the laboratory

August 14, 2018
In order to better understand important biological membranes, it is necessary to explore new methods. Researchers at Vienna University of Technology (Vienna) have succeeded in creating an artificial placental barrier on a ...

Using DeepMind's neural network learning system to diagnose eye diseases

August 14, 2018
Three institutions working together have applied DeepMind's neural network learning system to the task of discovering and diagnosing eye diseases. Moorfields Eye Hospital has been working with Google's DeepMind Health subsidiary ...

3-D printed biomaterials for bone tissue engineering

August 13, 2018
When skeletal defects are unable to heal on their own, bone tissue engineering (BTE), a developing field in orthopedics can combine materials science, tissue engineering and regenerative medicine to facilitate bone repair. ...

Artificial intelligence platform screens for acute neurological illnesses

August 13, 2018
An artificial intelligence platform designed to identify a broad range of acute neurological illnesses, such as stroke, hemorrhage, and hydrocephalus, was shown to identify disease in CT scans in 1.2 seconds, faster than ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.